Clinical Benefit of Topoisomerase Downregulation
Clinical trial NCT00250094 · COMPLETED
Trial details
- NCT number
- NCT00250094
- Sponsor
- New Mexico Cancer Research Alliance
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2004-05-01
- Primary completion
- 2005-06-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.